FundedIQ
Health Care

Lapix Therapeutics: Funding, Investors & Team (Aug 2026)

Lapix Therapeutics is a company that focuses on immune system modulation, aiming to develop treatments that can slow the progression of disease, maintain a strong immune response, and improve the safety profiles of other medications.

www.lapixtherapeutics.com LinkedIn Boston, United States 11-50 employees
Health Care Medical Therapeutics B2B
Total raised
$8.1M
Rounds
2
Latest
Undisclosed round
Aug 2024

Lapix Therapeutics has raised $8.1M across 2 funding rounds on record, the most recent an undisclosed round of $2.2M announced in Aug 2024.

That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

Lapix Therapeutics Company Profile and Key Stats

Total funding raised
$8.1M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$2.2M in Aug 2024
Employees
11-50
reported band
Headquarters
Boston, United States

Latest funding round on record: Aug 2024.

Lapix Therapeutics Funding Rounds

Date
Round
Amount
Undisclosed round
$2.2M
Undisclosed round
$5.9M

Lapix Therapeutics raised $5.9M in an undisclosed round announced in Apr 2023.

1.3 years later, an undisclosed round of $2.2M was announced in Aug 2024.

Lapix Therapeutics Founders and Leadership Team

Name
Role
Contact
Anas Fathallah
Founder

No contact details are on record for this team yet.

Lapix Therapeutics Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
29,722
$7.5M

Lapix Therapeutics' latest round of $2.2M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Lapix Therapeutics in Health Care and Boston

Companies Similar to Lapix Therapeutics

https://metriport.com

Series A $26.0M

There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…

Series A $17.0M

Serif Health provides healthcare price intelligence and contract management solution.

Private Equity $5.7M

Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…

Undisclosed round $5.0M

Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…

Seed $750k

TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…

Series A $10.0M

Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.

Undisclosed round $1.5M

Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…

Undisclosed round $3.0M

Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…

Series A $14.0M

Happy Health is a mission-driven technology company committed to transforming mental health awareness through…

Undisclosed round $75.0M

Leal Therapeutics creates new treatments for patients.

Series A $30.0M

Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…

Series A $18.3M

Lapix Therapeutics Funding FAQs

What does Lapix Therapeutics do?

Lapix Therapeutics is a company that focuses on immune system modulation, aiming to develop treatments that can slow the progression of disease, maintain a strong immune response, and improve the safety profiles of other medications.

How much funding has Lapix Therapeutics raised?

Lapix Therapeutics has raised $8.1M across 2 rounds on record. The most recent is an undisclosed round of $2.2M announced in Aug 2024.

When did Lapix Therapeutics last raise funding?

Lapix Therapeutics' most recent funding round on record is an undisclosed round of $2.2M, announced in Aug 2024.

Who founded Lapix Therapeutics?

FundedIQ lists Anas Fathallah (Founder) at Lapix Therapeutics.

Where is Lapix Therapeutics headquartered?

Lapix Therapeutics is based in Boston, Massachusetts, United States.

How many employees does Lapix Therapeutics have?

Lapix Therapeutics is in the 11-50 employee band.

How does Lapix Therapeutics' funding compare to other Health Care startups?

Lapix Therapeutics' latest round of $2.2M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's Lapix Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lapix Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.